Bank of Big Brother: Exploring a National Digital Currency Future

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Joe Selvaggi talks with financial privacy and digital currency expert Nicholas Anthony of CATO Institute Center for Monetary and Financial Alternatives about the potential benefits and risks were the U.S. to adopt a national digital currency.

Guest:

Nicholas Anthony is a policy analyst in the Cato Institute’s Center for Monetary and Financial Alternatives and a fellow at the Human Rights Foundation. Anthony’s research covers a wide range of topics within the field of monetary and financial economics, including financial privacy, cryptocurrencies, and the use of money in society. His work has been published in the Wall Street Journal, MarketWatch, Business Insider, the American Institute for Economic Research, and others. Originally from Baltimore, Anthony received a BS in economics and business administration from Towson University and an MA in economics from George Mason University.

WATCH:

Recent Episodes

The Oldest Hatred: Calling Out Antisemitism In Its Many Forms

Hubwonk host Joe Selvaggi talks with Boston Globe opinion writer Jeff Jacoby about the troubling increase in antisemitic incidents, including the recent attack on a Boston rabbi, and how our current political rancor fans the flames of bigotry nationwide.

Court Preserves Privacy: First Amendment Ruling Defends Non-Profits From Modern-Day McCarthyism

Hubwonk Host Joe Selvaggi talks with CATO research fellow and constitutional scholar Trevor Burrus about the recent Supreme Court ruling, Americans For Prosperity Foundation v. Bonta, reaffirming the right to privacy by denying the state of California the right to compel non-profits to disclose their list of donors.

Renters’ Unsung Heroes: Small Landlords Endure Without Income or Relief

Hubwonk host Joe Selvaggi talks with MassLandlords’ Doug Quattrochi about ways landlords faced the challenges of being caught between tenants unable to pay rent during COVID-19 shutdown and having little or no programmatic relief from state and federal agencies.

Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute's Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.